News

Merry Christmas!

In celebration of the holiday season, Oval will be closed from Dec. 25, 2017 – Jan. 1, 2018. We wish our colleagues and friends around the world a happy and safe holiday season and a wonderful New Year.

Read More

BIO-Europe2017

Oval Medical will be attending BIO-Europe in Berlin from the 6th-8th November 2017. BIO-Europe is the preeminent partnering conference for the life sciences, bringing together international decision makers from the biotechnology, pharmaceutical and financial sectors. We welcome you to contact us if you wish to arrange a meeting.

Read More

PDA Europe 2017

Oval Medical Technologies and SMC Ltd. will be attending PDA Europe in Vienna from the 6th-8th November 2017. We will be exhibiting at booth 100 and 101 and would welcome the opportunity to discuss and demonstrate our delivery platforms and integrated approach to autoinjector design. We will also be demonstrating our injection characterisation system which…

Read More

CEO Barbara Lead supporting the Aurora Project

Oval Medical CEO Barbara Lead CEO will be supporting the Aurora Project – an initiative focused on patient centricity and patients as partners. The project will be meeting at eyeforpharma in Barcelona from the 14-16 March. Find out more about the project at the following link: https://lnkd.in/gVTtx6

Read More

SMC Ltd. Expands Drug Delivery Capabilities with Oval Medical Technologies Acquisition

[button link=”http://www.ovalmedical.com/wp-content/uploads/2016/12/SMCLtd_Oval_121316v3.pdf” bg_color=”#40b4e5″ window=”yes”]Download PDF[/button] Somerset, Wisconsin – SMC Ltd., a global contract manufacturer of pharmaceutical and finished medical devices, announced today that it has acquired Oval Medical Technologies Ltd., a specialty pharmaceutical device company developing next generation autoinjectors based in Cambridge, UK.   Oval’s autoinjector platforms address the unmet needs in the self-injection market…

Read More
input search string and hit enter